We have conducted a crossover, randomized, double-blind dietary trial that tested the hypothesis that gender influences the response of plasma lipids, in particular high density lipoprotein (HDL) cholesterol, to dietary tat plus cholesterol. Twenty-six men and 25 women were matched for age, low density lipoprotein (LDL) cholesterol, triglyceride, and body mass index (BMT). After a 2-week baseline low-fat (27% of calories), low-cholesterol period, subjects were given two isocaloric liquid supplements for 3 weeks each, one containing 31 g fat (56% saturated) and 650 mg cholesterol, and the other fat free. The baseline HDL 2 cholesterol level was significantly higher in women: 0.41 versus 026 mmol/1 (p<0.01). Importantly, women also showed a greater rise in HDL 2 cholesterol concentration with the fat/cholesterol supplement: 0.09 versus 0.03 mmol/1 (p<0.01). The greater increment in women was related to their higher baseline HDL 2 cholesterol levels. With the fat and cholesterol supplement, LDL cholesterol values rose from 3.76 to 4.04 mmol/1 in women and from 3.77 to 4.13 mmol/1 in men. The baseline LDL cholesterol value was found to account for about 35% of the variance in the rise in LDL cholesterol level with fat and cholesterol supplementation in both men and women <50 years. In men only, there was a significant effect of age: the change in LDL cholesterol with the fat/cholesterol supplement was 0.16 mmol/1 in those <50 and 0.54 mmol/1 in those >50 years old (p<0.01). Only hypercholesterolemic men and women responded with significant increases in LDL and HDL, cholesterol; subjects with initial plasma cholesterol levels <5.5 mmol/1 showed either no change or a rise in HDL 2 cholesterol level. Men with a BMI >25 kg/m 2 experienced no rise in HDL 2 cholesterol, whereas women with a similar degree of obesity showed a rise in HDL 2 cholesterol level that was no different from that seen in nonobese women. Thus, men and women differ significantly in their response to dietary fat and cholesterol: women respond with a greater rise in HDL 2 , whereas men, especially older men, transport excess cholesterol preferentially in LDL. These findings were highly repeatable; when 15 subjects were retested after 6 months, the responses on the two occasions were significantly correlated (r=0.63,p<0.01). ( 2 were restricted to men, but the quantitative relation developed from these results has been freely generalized to women as well. However, men and women have differences in the distribution of lipoprotein lipids 3 as well as some enzymes that control lipoprotein metabolism.
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3 This fall in HDL cholesterol level is probably related to the activation of Although many dietary trials have included women, no controlled dietary trial has specifically compared matched groups of men and women to determine whether there is a specific gender effect. There is some evidence that women experience greater changes in HDL cholesterol concentration than do men, but this finding has not been consistent. 9 " 12 Although there are large interindividual differences in response to both dietary cholesterol and fatty acids, 13 -15 the response of groups is reasonably predictable. 1 -2 - 16 We have tested the hypothesis that men and women differ in the responsiveness of their plasma lipids, particularly HDL 2 cholesterol, to dietary fat and cholesterol. We have also repeated the same experiment in some of the subjects to assess the reproducibility of the findings. Katan Methods Healthy volunteers aged 25-65 years were recruited by public advertisement. All were free of cardiac, renal, and hepatic diseases. Subjects taking lipid-lowering medication were excluded; two women in the > 50-year age group were on combined hormone replacement therapy, but there were no women taking oral contraceptives. Twenty-six men and 25 women were matched pairwise for age, plasma cholesterol, triglyceride, and BMI. The total plasma cholesterol level before entry into the trial ranged from 4.5 to 7.8 mmol/1 (mean, 5.9), triglyceride level from 0.6 to 2.1 mmol/1 (mean, 1.2), and HDL cholesterol level from 0.9 to 2.3 mmol/1 (mean, 1.3). Thirteen men and 13 women were hypercholesterolemic (cholesterol >5.5 mmol/1). There were no subjects with a clinical diagnosis of familial hypercholesterolemia. Their age ranged from 35 to 66 years (mean, 49.3 years) and BMI from 19 to 31 kg/m 2 (mean, 24.8 in women; 25.0 in men). The study was approved by the Human Ethics Committee of the CSIRO, Division of Human Nutrition, and written consent was obtained from each subject.
Study Design
The study was performed in free-living subjects who attended the clinic on an outpatient basis. Subjects were placed on a low-fat diet (25% of calories as fat, cholesterol <250 mg/day), which they followed for the duration of the study. After a 2-week baseline period, a milk protein-based liquid supplement was added for the next 6 weeks. Two supplements were supplied, one containing 31 g fat (56% saturated fat, 17% poh/unsaturated fat) and 650 mg cholesterol, and the other containing no fat or cholesterol but isocaloric with the first (Table 1 ). The volume of supplement given (250 ml) was the same for all subjects and thus not corrected for estimated caloric intake. The supplements were given in random order for 3 weeks each. The study was double-blind. The supplements were very palatable, and the volunteers could not reliably distinguish between them. A trained dietitian provided information on sources of dietary fat to enable the subjects to achieve the 25% fat baseline diet. Weighed-food records were kept for 3 days in each experimental period. The records were analyzed with DIARYAN, 20 a mainframe program with a data base based on the work of McCance and Widdowsons 21 but supplemented with relevant Australian food data. The diaries showed excellent compliance. The achieved baseline diet contained 27% of energy as fat and 164 mg/day cholesterol. Other lifestyle factors were also controlled throughout the study: subjects were instructed not to change their exercise patterns or their drinking habits for the duration of the study; leisure physical activity and alcohol consumption were regulated; and habitual heavy drinkers (>10% of calories as alcohol) were excluded. There was only one light smoker (a woman) in the study. Compliance was monitored by questionnaire at each visit. There was no difference between men and women in either the amount of physical activity or the amount of alcohol consumed, and there were no changes across each experimental period. There was no difference between younger and older subjects or between lean and obese subjects in exercise patterns or alcohol consumption. Coffee and tea consumption was not controlled.
Fasting blood samples were taken on two occasions at the end of the baseline period and on 3 successive days at the end of each experimental period. Subjects were weighed at each visit and received further instruction from the dietitian. Body weights did not change significantly.
Plasma was separated by low-speed centrifugation and immediately frozen at -20°C. All measurements were performed in one run at the end of the trial. Plasma and lipoprotein lipids were measured on a Cobas Bio centrifugal analyzer (Roche Diagnostica, Basel, Switzerland) by using Roche enzymatic kits and control sera. HDL 2 and HDL3 subtractions were prepared by selective precipitation 22 by using Dextralip (Sochibo, France) and magnesium. LDL was calculated with the Friedewald equation (Friedewald et al 23 ). The coefficient of variation (CV) of the cholesterol and triglyceride assays was 1.6%, whereas the CV for HDL cholesterol was 1.9%; for HDL, cholesterol, 3.1%; and for HDL 2 cholesterol, 6.0%. The CV for samples on 3 successive days was 2.9±0.14% for cholesterol, 14.0+0.8% for triglyceride, 4.2±0.3% for LDL cholesterol, 3.6±0.3% for HDL cholesterol, 4.4±0.3% for HDL, cholesterol, and 14.5 ±1.8% for HDL 2 cholesterol.
Statistics
Covariate analysis of variance (ANOVA) and multiple regression were performed by using GENSTAT 5 (Lawes Agricultural Trust, Rothamsted Experimental Station) on a MicroVax computer. Two-tailed paired Student's t tests also were performed. As there was a significant difference between men and women in the change in fat and cholesterol intakes, expressed as a percentage of calories or as milligrams per 1,000 kilocalories, this was accounted for in a separate ANOVA by using the diet data as covariates. As the formal hypothesis is that changes in HDL cholesterol with a high-fat, high-cholesterol diet are not the same in men and women, this was accorded half of the significance (2p< 0.025), whereas a Bonferroni correction was applied to the other tests. All of the data were normally distributed. A rise of 5% in plasma cholesterol level was selected as the definition of responsiveness, as, based on the data of Irwig et al 24 and the observed change in plasma cholesterol, the estimated true change is 5% with 80% confidence limits of 1.5% and 8%.
Results
The volunteers were originally matched on the basis of a single fasting sample while consuming their usual diets. At the end of the baseline period on a 27% fat diet, the men and women were still well matched overall, although there were some differences when the groups were separated into the two age ranges (see Table 2 ). Both total cholesterol and LDL cholesterol were higher in women over 50 years compared with men of the same age, although not significantly so. HDL 2 cholesterol was significantly higher in women than in men (overall, p<0.01; <50 years, p<0.02). In the splitplot ANOVA with covariates, some of the variance in HDL cholesterol was accounted for by plasma triglycerides (F probability=0.002), gender (/?=0.007), alcohol intake (p=0.02), and weight (/7=0.024); for HDL 2 cholesterol, by triglycerides (p = 0.002), gender (p=0.004), and alcohol intake (/>=0.003); and for HDL3, by weight (p=0.025). BMI did not contribute to the variance in HDL cholesterol in this group.
The dietary data, as assessed by weighed-food records, showed good compliance with the instructed diet (Table 3) . During the baseline period women achieved a fat intake of 27.6% of calories and men of 27.3%. The addition of the fat-free supplement lowered this further to 21.7% and 22.5%, respectively (p<0.01), but it increased the total caloric intake by 11.5% for women, from 1,512 to 1,734 kcal/day (/><0.02), and by 10.7% for men, from 2,098 to 2,250 kcal/day. Cholesterol intake was low in the baseline and cholesterol-free supplement periods (between 84 and 109 mg/1,000 kcal) with no differences between men and women. Alcohol intake did not differ, at 4.2% and 4.5% of energy for women and men, respectively. The high-fat, high-cholesterol supplement increased the fat energy intake to 37.6% in women and 33.9% in men, with cholesterol intakes of 498 and 393 mg/1,000 kcal, respectively. This difference between men and women in the change in fat and cholesterol intake was significant (p<0.02). The polyunsaturated to saturated fat ratio decreased from 0.64 to 0.38 in women and from 0.61 to 0.46 in men. Energy intake increased slightly (by 3-4%) to 1,806 (in women) and to 2,353 (in men) kcal/day. Weight increased by 0.27±0.14 kg (mean±SEM) in women and by 0.07±0.16 in men during the high-fat, high-cholesterol period. There was no difference between any of the subgroups in weight changes throughout the experimental period.
Compared with the fat-free supplement period, addition of the fat and cholesterol supplement produced significant rises in total cholesterol, LDL cholesterol, and HDL cholesterol and a significant fall in triglyceride levels (Table 4) . Women showed greater changes than men in HDL 2 cholesterol, 21.5% versus 11% (p<0.01), with no significant differences in HDL, cholesterol, LDL cholesterol, or triglycerides. The rise in HDL cholesterol level was somewhat more consistent (in 88% of women and 81% of men) than the rise in LDL cholesterol level (in 72% and 73%, respectively). Men had a 30% higher energy intake than women, so the high-fat, high-cholesterol supplement produced an increase in fat calories and cholesterol that was 28% smaller than in women. Using the calculated dietary fat and cholesterol as covariates reduced the difference between men and women for HDL 2 from 0.06 mmol/1 (/><0.01) to 0.05 mmol/1 (/?<0.02). An additional 30% of the high-fat, high-cholesterol supplement in men would have been expected to augment the increase in LDL cholesterol by 30%, to 0.47 mmol/1, and the increases in HDL cholesterol to 0.14 mmol/1 (HDL3, 0.11 and HDL 2 , 0.04). However, this would not have affected the ratio of an increase in HDL to an increase in LDL cholesterol in men, 0.30, which is different from that for women (0.71). In men the observed HDL to LDL cholesterol ratio remained unchanged at 0.32±02 with the fat/cholesterol supplement, whereas in women the ratio increased by 7%, from 0.39±0.04 to 0.42±0.03. Based on the Keys equation, total plasma cholesterol would have been expected to rise by 0.90 and 0.71 mmol/1 for women and men, respectively; the changes that occurred were much less, i.e., 0.40 and 0.43 mmol/1, respectively. Apart from the effect of gender, preexisting hypercholesterolemia, age, and BMI (in men only) influenced the response to a high-fat, high-cholesterol diet (Table 5 ) and will be discussed in more detail below.
There were differences between men and women in the effect of age on dietary responsiveness (Table 4) . Women showed small changes with aging, whereas older men showed enhanced dietary responsiveness. In men younger than 50 years, diet had little effect, whereas in men 50 years or older, LDL cholesterol as well as HDL 2 and HDL3 cholesterol rose significantly (p<0.01). In men, age contributed about 30% of the variance in the change in LDL cholesterol (p=0.002). There were no differences between premenopausal and postmenopausal women in dietary response; the >50-year cutoff in Tables 2 and 4 divided women into premenopausal and postmenopausal groups. Changes in LDL and HDL3 cholesterol with the fat/cholesterol supplement were also related to baseline plasma total cholesterol levels. In men with a total cholesterol level <5.5 mmol/1, there were no significant changes with the supplement, and in women, only HDL 2 rose (by 20.4%,/?<0.01). However, in hypercholesterolemic women there were rises in HDL 2 (23%, /><0.001), HDL, (17%, p<0.001), and LDL (8.5%, p<0.01) cholesterol; in hypercholesterolemic men there was a small rise in HDL3 cholesterol (8.9%,/?<0.01) and a very large rise in LDL cholesterol (15.2%, p<0.001). The difference between the normocholesterolemic and hypercholesterolemic groups was significant for LDL cholesterol (p<0.01) in men and for HDL3 cholesterol (/?<0.01) in women.
In subjects with a BMI >25 kg/m 2 , there were no significant baseline differences between men and women in HDL 2 cholesterol, but there were significant differences in the response of HDL 2 to the fat/cholesterol supplement. In obese men there was no response at all, whereas in obese women there was a 27% increase in HDL 2 (p<0.01). In nonobese subjects HDL 2 levels were higher in both men and women than in obese subjects, but despite higher baseline levels of HDL 2 in women, there was no difference between men and women in dietary response.
By covariate ANOVA, all of the differences between men and women in the increase in HDL 2 cholesterol and almost all of the effect of age on dietary responsiveness in men were attributable to the differences present at baseline. Thus, while controlling for age, BMI, and baseline LDL, HDL3, and HDL 2 cholesterol, gender made little contribution (p=0.11) to the change in HDL 2 cholesterol. While controlling for BMI and baseline lipids, age contributed little to the effect of diet on HDL 2 (p = 0.54), HDL 3 (/>=0.07), and LDL (p=0.64) cholesterol. By multiple-regression analysis (Table 6) , it was found that in both men and women baseline levels of HDL 2 could account for 25% of the variance in the response of HDL 2 to the fat and cholesterol supplement (p=0.0002), and baseline levels of LDL could account for 17% of the variance in LDL response (p=0.003). The predictive power of baseline LDL cholesterol levels was seen in men in both age groups (35%, p=0.002) but only in women <50 years old (37%,/?=0.02). When the changes in plasma lipids were expressed as the percent change, the following correlations were apparent: changes in LDL and HDL3 cholesterol (r=0.45,/?<0.001); changes in HDL 2 cholesterol and body weight (r=-0.35,/?<0.01); and changes in triglyceride and baseline LDL cholesterol (r=0.33, p<0.01). Baseline dietary cholesterol and fat intakes were unrelated to dietary response. Fifteen of the volunteers repeated the study 6 months later with exactly the same trial format. There was good correlation between the two studies in the change in total cholesterol with the fat/cholesterol supplement (r=0.63, /?<0.01) and a weaker one with HDL cholesterol (r=0.49, p<0.05). The change in plasma cholesterol in the second trial was 7.3% (p<0.01) compared with 10% (p<0.01) for the same individuals in the first trial. With either a 5% or a 10% increase in cholesterol as the definition of dietary sensitivity, 70% of the subjects remained in the same category in both trials. Volunteers consumed 100% of the supplements in both trials and showed good compliance with the basal diet.
Discussion
We have demonstrated that women show greater elevations of HDL 2 cholesterol than do men in response to a fat and cholesterol supplement. In both men and women, the HDL 2 cholesterol concentration on the 27% fat baseline diet partially predicted the response to the supplement. This suggests that women have higher HDL cholesterol levels than men partly because they are more efficient than men at channeling dietary cholesterol into HDL 2 , presumably by enhanced transfer of free cholesterol to HDL from trigryceride-rich particles during lipolysis. The stimulation of HDL production by saturated fat may also be greater in women. Although a specific gender effect disappears in the analysis when baseline variables are accounted for, part of the reason for different baseline lipid levels may lie in differing responses to the fat and cholesterol in the low-fat diet. There are other well-documented metabolic reasons for the high level of HDL 2 in women, such as decreased hepatic lipase 5 -6 and increased lipoprotein lipase activities. 4 - 5 The concentration of HDL 2 cholesterol is positively correlated with adipose tissue lipoprotein lipase activity and negatively correlated with hepatic lipase activity in both men and women. 5 - 25 Women experience greater increases in HDL 2 mass, phospholipid, apolipoprotein (apo) A-I, and apo A-II after a high-fat meal than do men. 4 -26 In a study during which egg consumption ceased, Beynen and Katan 17 found that only women showed a significant fall in HDL cholesterol level (6.2%), whereas men showed no significant changes in HDL cholesterol level. Moreover, the change in HDL cholesterol was correlated with the baseline HDL cholesterol, which could account for 18% of the variance. In our study, baseline HDL cholesterol could account for 25% of the variance. However, in a later study by Mensink and Katan, 27 replacement of saturated fat by monounsat- urated fat or carbohydrate led to greater differences in HDL cholesterol in men than in women (0.32 mmol/1 versus 0.13 mmol/1), but the subjects were not matched as they were in our study. Cholesterol intake was not significantly different between dietary phases, and this may explain the contrast in results. Ferro-Luzzi et al, 28 in a report on the effect of changing from the "Mediterranean diet" to one high in saturated fat, noted in 25 couples that HDL cholesterol level increased by 19% in women but showed no change in men. Changes in LDL cholesterol level were similar. The increase in dietary cholesterol was only 100 mg/day. In a study that examined the influence of apo E phenotype on dietary responsiveness, Savolainen et al 29 found that men had a significantly greater rise in LDL cholesterol with a large increase in saturated fat intake (19% of calories) than did women and a small increase in cholesterol intake (180 mg/day). There were no differences in HDL cholesterol, nor did apo E phenotype influence the results. The subjects in the Finnish trial were considerably younger than in our trial, and their LDL cholesterol level was 24% higher in men than in women. Thus, for recent trials involving both men and women, two showed greater changes in HDL cholesterol in women, one showed greater changes for men, and one showed no difference. However, in none of these trials were the men and women completely matched, and furthermore, some of the trials were small. With the inclusion of our trial, the balance of evidence would favor women showing greater changes than men in HDL cholesterol level. A crossover trial containing 52 subjects and a population CV of 22% for HDL and of 43% for HDL 2 would have sufficient power (80%) to detect a 9% difference in HDL cholesterol and a 17% difference in HDL 2 cholesterol levels with a two-way p< 0.05. The observed values were 7% (/7<0.05) and 18% (p<0.02), respectively.
Apart from the effect of gender, three other factors determined the outcome of fat/cholesterol supplementation on univariate analysis: preexisting hypercholesterolemia, and in men only, age and BMI. Younger men showed a rise in HDL 2 cholesterol only while older men responded with significant increments in LDL and HDL3 cholesterol concentration. This may reflect a deterioration in lipoprotein clearance that has been reported to occur with age. The clearance of lipemia after a fat meal deteriorates with age, 30 and the fractional catabolic rate of LDL slows with aging. 31 Men with a BMI >25 kg/m 2 had a particularly adverse response to fat and cholesterol, with a rise in LDL cholesterol level over five times greater than that in HDL cholesterol and no rise in HDL 2 cholesterol. Women appeared to show no adverse effects from this modest rise in body weight. This may be related to a change in fat distribution, with more abdominal fat in men but not in women.
We have previously reported that normocholesterolemic subjects respond to dietary cholesterol mainly by an increase in HDL cholesterol, whereas LDL cholesterol rose in hypercholesterolemic subjects. 32 It may well be that in the subjects who were initially mildly hypercholesterolemic, the regulation of cholesterol and particularly of LDL cholesterol was less efficient than in those who were normocholesterolemic. Several dysfunctions in LDL metabolism have been reported in pohygenic hypercholesterolemia. These include both overproduction and diminished clearance of LDL. In this group of normocholesterolemic and mildly hypercholesterolemic men and women, baseline LDL cholesterol levels could account for as much as 35-37% of the variance in the rise in LDL cholesterol with the fat/cholesterol supplement. This suggests that some of the differences between individuals in baseline LDL cholesterol could be related to differences in response to dietary fat and cholesterol; this response appears to be reasonably reproducible. The genetic basis for differences in dietary sensitivity is not known, although we have identified enhanced sensitivity associated with the minor allele of the EcoRl apo B polymorphism. 35 These studies show that the response to dietary fat and cholesterol is heterogeneous for several variables. Importantly, some groups of subjects respond by preferentially using HDL 2 cholesterol for any rise in plasma total cholesterol. Others respond in a presumably less favorable manner by transporting excess plasma cholesterol in LDL cholesterol. Women, younger people, and those with a lower plasma cholesterol level and a lower BMI showed the more favorable response. The higher HDL 2 levels found in women may partly stem from their response to dietary fat and cholesterol. The difference of 0.09 mmol/1 (3.5 mg/dl) in HDL cholesterol and 0.06 (2.3 mg/dl) mmol/1 in HDL 2 cholesterol between men and women in their response to a high-fat, high-cholesterol diet translates into a potential increase in the risk of myocardial infarction in men of 7-13% compared with women on the same diet. 36 The benefits of a low-fat, low-cholesterol diet would appear to be slightly greater for men despite the same change in total cholesterol, as there is a greater fall in LDL cholesterol and a smaller fall in HDL cholesterol level.
